NovaBay Pharmaceuticals Inc (NBY)
0.7198
+0.01
(+1.52%)
USD |
NYAM |
Nov 21, 16:00
0.7093
-0.01
(-1.46%)
After-Hours: 20:00
NovaBay Pharmaceuticals Total Assets (Quarterly): 3.877M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.877M |
June 30, 2024 | 3.925M |
March 31, 2024 | 5.357M |
December 31, 2023 | 9.034M |
September 30, 2023 | 12.85M |
June 30, 2023 | 16.01M |
March 31, 2023 | 14.82M |
December 31, 2022 | 16.40M |
September 30, 2022 | 22.38M |
June 30, 2022 | 21.54M |
March 31, 2022 | 24.79M |
December 31, 2021 | 23.98M |
September 30, 2021 | 12.24M |
June 30, 2021 | 13.60M |
March 31, 2021 | 14.07M |
December 31, 2020 | 15.24M |
September 30, 2020 | 17.08M |
June 30, 2020 | 13.27M |
March 31, 2020 | 9.475M |
December 31, 2019 | 11.22M |
September 30, 2019 | 14.60M |
June 30, 2019 | 9.87M |
March 31, 2019 | 9.72M |
December 31, 2018 | 9.361M |
September 30, 2018 | 10.36M |
Date | Value |
---|---|
June 30, 2018 | 11.70M |
March 31, 2018 | 13.82M |
December 31, 2017 | 10.08M |
September 30, 2017 | 11.06M |
June 30, 2017 | 12.07M |
March 31, 2017 | 12.68M |
December 31, 2016 | 15.38M |
September 30, 2016 | 15.14M |
June 30, 2016 | 7.005M |
March 31, 2016 | 4.931M |
December 31, 2015 | 5.077M |
September 30, 2015 | 6.69M |
June 30, 2015 | 10.17M |
March 31, 2015 | 8.155M |
December 31, 2014 | 7.537M |
September 30, 2014 | 11.04M |
June 30, 2014 | 13.51M |
March 31, 2014 | 17.18M |
December 31, 2013 | 15.65M |
September 30, 2013 | 12.24M |
June 30, 2013 | 12.83M |
March 31, 2013 | 15.42M |
December 31, 2012 | 19.24M |
September 30, 2012 | 13.67M |
June 30, 2012 | 12.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.877M
Minimum
Sep 2024
24.79M
Maximum
Mar 2022
14.06M
Average
13.84M
Median
Total Assets (Quarterly) Benchmarks
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Theriva Biologics Inc | 40.11M |
Oragenics Inc | 5.204M |
Nanoviricides Inc | 11.74M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.805M |
Shareholders Equity (Quarterly) | 1.072M |
Debt to Equity Ratio | 0.0476 |
Current Ratio | 1.149 |
Net Debt Paydown Yield | 6.74% |